Inhibition of Apoptosome Formation by Suppression of Hsp90β Phosphorylation in Tyrosine Kinase-Induced Leukemias

REFERENCES

• Abu-Duhier, F. M., A. C. Goodeve, G. A. Wilson, R. S. Care, I. R. Peake, and J. T. Reilly. 2001. Identification of novel FLT-3 Asp835 mutations in adult acute myeloid leukaemia. Br. J. Haematol. 113:983–988.
   PubMed Web of Science ®Google Scholar
• Amarante-Mendes, G. P., A. J. McGahon, W. K. Nishioka, D. E. Afar, O. N. Witte, and D. R. Green. 1998. Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL. Oncogene 16:1383–1390.
   PubMed Web of Science ®Google Scholar
• An, W. G., T. W. Schulte, and L. M. Neckers. 2000. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth Differ. 11:355–360.
   PubMedGoogle Scholar
• Beere, H. M. 2005. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J. Clin. Investig. 115:2633–2639.
   PubMed Web of Science ®Google Scholar
• Bhatia, R., M. Holtz, N. Niu, R. Gray, D. S. Snyder, C. L. Sawyers, D. A. Arber, M. L. Slovak, and S. J. Forman. 2003. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood 101:4701–4707.
   PubMed Web of Science ®Google Scholar
• Brandts, C. H., B. Sargin, M. Rode, C. Biermann, B. Lindtner, J. Schwäble, H. Buerger, C. Müller-Tidow, C. Choudhary, M. McMahon, W. E. Berdel, and H. Serve. 2005. Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation. Cancer Res. 65:9643–9650.
   PubMed Web of Science ®Google Scholar
• Cain, K., D. G. Brown, C. Langlais, and G. M. Cohen. 1999. Caspase activation involves the formation of the aposome, a large (∼700 kDa) caspase-activating complex. J. Biol. Chem. 274:22686–22692.
   PubMed Web of Science ®Google Scholar
• Cardone, M. H., N. Roy, H. R. Stennicke, G. S. Salvesen, T. F. Franke, E. Stanbridge, S. Frisch, and J. C. Reed. 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318–1321.
   PubMed Web of Science ®Google Scholar
• Chen, M. S., A. M. Silverstein, W. B. Pratt, and M. Chinkers. 1996. The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. J. Biol. Chem. 271:32315–32320.
   PubMed Web of Science ®Google Scholar
• Clark, J. J., J. Cools, D. P. Curley, J. C. Yu, N. A. Lokker, N. A. Giese, and D. G. Gilliland. 2004. Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518. Blood 104:2867–2872.
   PubMed Web of Science ®Google Scholar
• Danial, N. N., and S. J. Korsmeyer. 2004. Cell death: critical control points. Cell 116:205–219.
   PubMed Web of Science ®Google Scholar
• Deming, P. B., Z. T. Schafer, J. S. Tashker, M. B. Potts, M. Deshmukh, and S. Kornbluth. 2004. Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial cytochrome c release. Mol. Cell. Biol. 24:10289–10299.
   PubMedGoogle Scholar
• Garnier, C., D. Lafitte, T. J. Jorgensen, O. N. Jensen, C. Briand, and V. Peyrot. 2001. Phosphorylation and oligomerization states of native pig brain HSP90 studied by mass spectrometry. Eur. J. Biochem. 268:2402–2407.
   PubMedGoogle Scholar
• Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland. 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307–316.
   PubMed Web of Science ®Google Scholar
• Gorre, M. E., M. Mohammed, K. Ellwood, N. Hsu, R. Paquette, P. N. Rao, and C. L. Sawyers. 2001. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876–880.
   PubMed Web of Science ®Google Scholar
• Gorre, M. E., K. Ellwood-Yen, G. Chiosis, N. Rosen, and C. L. Sawyers. 2002. BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90. Blood 100:3041–3044.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hériché, J. K., and E. M. Chambaz. 1998. Protein kinase CK2α is a target for the Abl and Bcr-Abl tyrosine kinases. Oncogene 17:13–18.
   PubMed Web of Science ®Google Scholar
• Hoover, R. R., F. X. Mahon, J. V. Melo, and G. Q. Daley. 2002. Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336. Blood 100:1068–1071.
   PubMed Web of Science ®Google Scholar
• Horita, M., E. J. Andreu, A. Benito, C. Arbona, C. Sanz, I. Benet, F. Prosper, and J. L. Fernandez-Luna. 2000. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J. Exp. Med. 191:977–984.
   PubMed Web of Science ®Google Scholar
• Hu, Y., L. Ding, D. M. Spencer, and G. Nunez. 1998. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J. Biol. Chem. 273:33489–33494.
   PubMedGoogle Scholar
• Isaacs, J. S., W. Xu, and L. Neckers. 2003. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 3:213–217.
   PubMed Web of Science ®Google Scholar
• Kuo, C. C., C. M. Liang, C. Y. Lai, and S. M. Liang. 2007. Involvement of heat shock protein (Hsp)90β but not Hsp90α in antiapoptotic effect of CpG-B oligodeoxynucleotide. J. Immunol. 178:6100–6108.
   PubMedGoogle Scholar
• Lees-Miller, S. P., and C. W. Anderson. 1989. Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J. Biol. Chem. 264:2431–2437.
   PubMed Web of Science ®Google Scholar
• Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479–489.
   PubMed Web of Science ®Google Scholar
• Liu, X., C. N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157.
   PubMed Web of Science ®Google Scholar
• Michor, F., T. P. Hughes, Y. Iwasa, S. Branford, N. P. Shah, C. L. Sawyers, and M. A. Nowak. 2005. Dynamics of chronic myeloid leukaemia. Nature 435:1267–1270.
   PubMed Web of Science ®Google Scholar
• Mimnaugh, E. G., P. J. Worland, L. Whitesell, and L. M. Neckers. 1995. Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp60v-src tyrosine kinase. J. Biol. Chem. 270:28654–28659.
   PubMed Web of Science ®Google Scholar
• Mishra, S., A. Reichert, J. Cunnick, D. Senadheera, B. Hemmeryckx, N. Heisterkamp, and J. Groffen. 2003. Protein kinase CKIIα interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells. Oncogene 22:8255–8262.
   PubMed Web of Science ®Google Scholar
• Nakao, M., S. Yokota, T. Iwai, H. Kaneko, S. Horiike, K. Kashima, Y. Sonoda, T. Fujimoto, and S. Misawa. 1996. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 10:1911–1918.
   PubMed Web of Science ®Google Scholar
• Neshat, M. S., A. B. Raitano, H. G. Wang, J. C. Reed, and C. L. Sawyers. 2000. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf. Mol. Cell. Biol. 20:1179–1186.
   PubMed Web of Science ®Google Scholar
• Nimmanapalli, R., L. Fuino, P. Bali, M. Gasparetto, M. Glozak, J. Tao, L. Moscinski, C. Smith, J. Wu, R. Jove, P. Atadja, and K. Bhalla. 2003. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res. 63:5126–5135.
   PubMed Web of Science ®Google Scholar
• Ogiso, H., N. Kagi, E. Matsumoto, M. Nishimoto, R. Arai, M. Shirouzu, J. Mimura, Y. Fujii-Kuriyama, and S. Yokoyama. 2004. Phosphorylation analysis of 90 kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 43:15510–15519.
   PubMed Web of Science ®Google Scholar
• Qin, H., S. M. Srinivasula, G. Wu, T. Fernandes-Alnemri, E. S. Alnemri, and Y. Shi. 1999. Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549–557.
   PubMed Web of Science ®Google Scholar
• Pandey, P., A. Saleh, A. Nakazawa, S. Kumar, S. M. Srinivasula, V. Kumar, R. Weichselbaum, C. Nalin, E. S. Alnemri, D. Kufe, and S. Kharbanda. 2000. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19:4310–4322.
   PubMed Web of Science ®Google Scholar
• Penserga, E. T., and T. Skorski. 2007. Fusion tyrosine kinases: a result and cause of genomic instability. Oncogene 26:11–20.
   PubMed Web of Science ®Google Scholar
• Plas, D. R., S. Talapatra, A. L. Edinger, J. C. Rathmell, and C. B. Thompson. 2001. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276:12041–12048.
   PubMedGoogle Scholar
• Raina, D., P. Pandey, R. Ahmad, A. Bharti, J. Ren, S. Kharbanda, R. Weichselbaum, and D. Kufe. 2005. c-Abl tyrosine kinase regulates caspase-9 autocleavage in the apoptotic response to DNA damage. J. Biol. Chem. 280:11147–11151.
   PubMed Web of Science ®Google Scholar
• Sanchez-Garcia, I., and G. Grutz. 1995. Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2. Proc. Natl. Acad. Sci. USA 92:5287–5291.
   PubMed Web of Science ®Google Scholar
• Schafer, Z. T., and S. Kornbluth. 2006. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev. Cell 10:549–561.
   PubMedGoogle Scholar
• Scheibel, T., H. I. Siegmund, R. Jaenicke, P. Ganz, H. Lilie, and J. Buchner. 1999. The charged region of Hsp90 modulates the function of the N-terminal domain. Proc. Natl. Acad. Sci. USA 96:1297–1302.
   PubMed Web of Science ®Google Scholar
• Scroggins, B. T., K. Robzyk, D. Wang, M. G. Marcu, S. Tsutsumi, K. Beebe, R. J. Cotter, S. Felts, D. Toft, L. Karnitz, N. Rosen, and L. Neckers. 2007. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 25:151–159.
   PubMed Web of Science ®Google Scholar
• Shuai, K., J. Halpern, J. ten Hoeve, X. Rao, and C. L. Sawyers. 1996. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247–254.
   PubMed Web of Science ®Google Scholar
• Silverstein, A. M., M. D. Galigniana, M. S. Chen, J. K. Owens-Grillo, M. Chinkers, and W. B. Pratt. 1997. Protein phosphatase 5 is a major component of glucocorticoid receptor. hsp90 complexes with properties of an FK506-binding immunophilin. J. Biol. Chem. 272:16224–16230.
   PubMedGoogle Scholar
• Skorski, T., A. Bellacosa, M. Nieborowska-Skorska, M. Majewski, R. Martinez, J. K. Choi, R. Trotta, P. Wlodarski, D. Perrotti, T. O. Chan, M. A. Wasik, P. N. Tsichlis, and B. Calabretta. 1997. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 16:6151–6161.
   PubMed Web of Science ®Google Scholar
• Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri. 1998. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1:949–957.
   PubMed Web of Science ®Google Scholar
• Stennicke, H. R., Q. L. Deveraux, E. W. Humke, J. C. Reed, V. M. Dixit, and G. S. Salvesen. 1999. Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274:8359–8362.
   PubMed Web of Science ®Google Scholar
• Unwin, R. D., D. W. Sternberg, Y. Lu, A. Pierce, D. G. Gilliland, and A. D. Whetton. 2005. Global effects of BCR/ABL and TEL/PDGFRβ expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR/ABL. J. Biol. Chem. 280:6316–6326.
   PubMedGoogle Scholar
• Voss, A. K., T. Thomas, and P. Gruss. 2000. Mice lacking HSP90β fail to develop a placental labyrinth. Development 127:1–11.
   PubMed Web of Science ®Google Scholar
• Wandinger, S. K., M. H. Suhre, H. Wegele, and J. Buchner. 2006. The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90. EMBO J. 25:367–376.
   PubMed Web of Science ®Google Scholar
• Weisberg, E., P. W. Manley, S. W. Cowan-Jacob, A. Hochhaus, and J. D. Griffin. 2007. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukemia. Nat. Rev. Cancer 7:345–356.
   PubMed Web of Science ®Google Scholar
• Whitesell, L., and S. L. Lindquist. 2005. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 5:761–772.
   PubMed Web of Science ®Google Scholar
• Xu, W., X. Yuan, Z. Xiang, E. Mimnaugh, M. Marcu, and L. Neckers. 2005. Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex. Nat. Struct. Mol. Biol. 12:120–126.
   PubMed Web of Science ®Google Scholar
• Yamamoto, Y., H. Kiyoi, Y. Nakano, R. Suzuki, Y. Kodera, S. Miyawaki, N. Asou, K. Kuriyama, F. Yagasaki, C. Shimazaki, H. Akiyama, K. Saito, M. Nishimura, T. Motoji, K. Shinagawa, A. Takeshita, H. Saito, R. Ueda, R. Ohno, and T. Naoe. 2001. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 97:2434–2439.
   PubMed Web of Science ®Google Scholar
• Yuan, J., and B. A. Yankner. 2000. Apoptosis in the nervous system. Nature 407:802–809.
   PubMed Web of Science ®Google Scholar
• Zhao, C., J. Blum, A. Chen, H. Y. Kwon, S. H. Jung, J. M. Cook, A. Lagoo, and T. Reya. 2007. Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528–541.
   PubMed Web of Science ®Google Scholar
• Zhao, Y. G., R. Gilmore, G. Leone, M. C. Coffey, B. Weber, and P. W. Lee. 2001. Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J. Biol. Chem. 276:32822–32827.
   PubMed Web of Science ®Google Scholar
• Zou, H., W. J. Henzel, X. Liu, A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405–413.
   PubMed Web of Science ®Google Scholar
• Zou, H., Y. Li, X. Liu, and X. Wang. 1999. An APAF-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274:11549–11556.
   PubMed Web of Science ®Google Scholar